Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burden

27 May 2022

Abstract excerpt

The total number of somatic mutations may affect the prognosis of cancer, so we applied bioinformatics methods to investigate the association between the TMB (tumor mutational burden)-related differentially expressed genes (DEGs) and the prognosis of hepatocellular carcinoma (HCC). We calculated the TMB value of the patients with HCC in TCGA database and identified the differentially expressed genes between the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35622212
DOI: 10.1007/s13577-022-00708-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burdenPMID 35622212Read ↗

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma.Semantic proximity Read ↗

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.Semantic proximity Read ↗

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read ↗

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinomaSemantic proximity Read ↗

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics AnalysisSemantic proximity Read ↗

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.Semantic proximity Read ↗

Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell InfiltrationSemantic proximity Read ↗

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics AnalysisSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular CarcinomaSemantic proximity Read ↗

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.